In an 8 week clinical trial, 90%
of the people who used Crown for 2 months said they wanted to buy more,
we have full confidence you will feel the same way!
90% of participants completely agreed
that the product was easy to use.85%
agreed that the product “worked fast” and “worked
well”. 77%
agreed they had measurable improvement..
CROWN’s
active compound has undergone three (3) Separate Clinical Evaluations:
Two (2) Clinical Trials (for efficacy)
One (1) Clinical Safety Test
See results:
Study Investigator: Pharmaceutical Chemist, Courtland Imel
Conducted Via: Ceutical
Labs, Analytical Testing Division
Size of Group: 28
participants, 27 results reported at conclusion.
Conclusion:
The
most notable response, a participant was able to synthesize new growth
in less under seven (7) days.
In 21 of 27 individuals change was recorded. 88% saw significant
changes. The product provided statistically significant evidence
between those who used it and those who did not. The differentiation
is the majority of subjects using it who saw a change in their scalp
and hair. “Significant” is described as individuals
seeing follicle development, hair growth, or increased hair growth.
In
the individuals where we did not note change, there was either no difference,
they failed to follow the usage instructions, or they discontinued the
study.
Source:
Ceutical Labs,
White Paper Research Evaluation
Study Investigator: Ed Boisits, Ph.D.
Site: International
Research Services, Inc.
Trial Identification: 3356TOL
STUDY DESIGN
A
monadic evaluation, beginning with (20) subjects, twelve (17) males
and three (3) females. Duration was an eight (8) week test period,
using one (1) test product according to directions supplied by
the sponsor. Hair condition was evaluated instrumentally using
image analysis and subjectively by panelists via questionnaire.
Digital photos were taken at baseline, week 4 and week 8. Visits
occurred at week 0 (baseline), week four (4) and week eight (8). |
RESULTS AND DISCUSSION
The objective of the present study
is to assess the efficacy of one (1) test product on hair condition,
with specific attention to improving the subjective appearance of fuller,
thicker hair. The study was conducted in two (2) groups totaling 20 subjects,
during an 8 week duration. No adverse reactions were reported.
Results of the subjective questionnaire
administered at week 8 are summarized as follows. Results indicate that
77% of the participants either completely agree or, very much agreed that they
saw visible, measurable improvement in the appearance of thicker hair. 90%
of the participants completely agreed that they felt
the product was easy to use. 70% of the respondents
either completely agreed, very much agreed, or somewhat
agreed that they could physically feel new growth of hair on
the scalp. Further, 85% of subjects either completely agreed,
very much agreed, or somewhat agreed that the product worked
fast and 75% that using the product made them feel good about
their hair.
90% of the participants either completely agreed, very
much agreed, or somewhat agreed that they would purchase
the product after using for the 2 month trial. 85%
of the participants indicated that the product worked either extremely
well, very well, or somewhat well.
Results of image analysis
of hair growth photographs are detailed in Table 4. The method analyzes
growth as percent coverage of the test area. The reason for this is
excessive hair growth in the test area from product usage, making it
difficult to precisely locate the shaved area. As
such, percent coverage increased from baseline to week 4 in all 20
subjects. Increases in percent coverage from week 4 to week 8 were
observed. Results of analysis support a significant increase
in coverage at week 4 to baseline as well as week 8 to week 4.
In conclusion, under the conditions employed in this study,
the majority of participants reported positive results with regard
to hair growth and fuller, thicker hair. These findings were corroborated
by the objective analysis of hair growth wherein increased growth was
detected. |
Source:
Clinical IRB Study; IRSI, Inc.
|